Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients
Caballero-Velázquez, Teresa, López-Corral, Lucia, Encinas, Cristina, Castilla-Llorente, Cristina, Martino, Rodrigo, Rosiñol, Laura, Sampol, Antonia, Caballero, Dolores, Serrano, David, Heras, InmaculaVolume:
162
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12410
Date:
August, 2013
File:
PDF, 157 KB
english, 2013